Veeva Systems Inc. announced during its 2026 Investor Day presentation on November 5, 2026, that it expects to report third quarter of fiscal year 2027 results that meet or exceed its previously announced guidance. The guidance, which was originally provided on August 26, 2026, i

Veeva Systems Inc. Expects to Meet or Exceed Q3’27 Guidance

In early trading on Tuesday, shares of Honeywell International topped the list of the day's best performing components of the S&P 500 index, trading up 7.5%.  Year to date, Honeywell International registers a 42.2% gain.

And the worst performing S&P 500 component thus f

S&P 500 Movers: WDC, HONIV  

In recent trading, shares of Veeva Systems Inc (Symbol: VEEV) have crossed above the average analyst 12-month target price of $294.60, changing hands for $296.13/share.  When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on

Veeva Systems Reaches Analyst Target Price

Key PointsGrail’s stock could skyrocket if the FDA approves Galleri.

2 Growth Stocks to Buy in October

Veeva Systems (VEEV) closed the most recent trading day at $281.93, moving 1.23% from the previous trading session.

Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors

Veeva Systems  is making that transformation happen.  The Pleasanton, Calif.–based company develops software for biotechnology and pharmaceutical customers to manage everything from research and development and regulatory submissions to day-to-day commercial operations.  Its software was originally built atop  Salesforce  but has since expanded to stand-alone applications.

AI Will Revolutionize Medicine. This Company Provides the Plumbing.

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Veeva Systems Inc. News